pubrio
Lutris Pharma

Lutris Pharma

Israel · Biotechnology

Pharmaceuticals

Biotechnology

Healthcare

Lutris Pharma is a clinical stage biopharmaceutical company focused on improving the effectiveness of anti-cancer therapy and the quality of life for patients treated with EGFR Inhibitors or radiation. The company aims to mitigate dermal toxicity, a common adverse reaction of these treatments, through novel topical therapies. Lutris Pharma has received FDA waivers, accelerating its development pathway to approval.

Company Insights
Company Overview

2015

Founded

Biotechnology

Industry

Israel

Location

2,965,765

Ranking

5 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Lutris Pharma

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​